Simple bedside ultrasound may spot lung risk in preemies
NCT ID NCT05925075
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a simple bedside lung ultrasound can predict chronic lung disease in premature infants born before 32 weeks. Researchers will perform ultrasounds on 150 babies with breathing problems and track their outcomes. The goal is to see if early ultrasound scores can identify those at risk for bronchopulmonary dysplasia.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify preterm infants at high risk for chronic lung disease earlier, allowing for timely interventions.
- What could go wrong
- This is an observational study, not a treatment trial. The ultrasound scores may not accurately predict outcomes in all babies, and results may not change current care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2023
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All infants who are born less than 32 weeks gestation will be enrolled in the study after obtaining parent's consent.
- Ages
-
0 days and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Infants born less than 32 weeks gestation and meet one or more of the below criteria A) Diagnosis of Respiratory Distress Syndrome B) Diagnosis of PDA C) Post-natal steroid treatment for the purpose of weaning off ventilation support Exclusion Criteria: Infants with critical congenital heart and lung conditions and those with genetic anomalies.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bronchopulmonary dysplasia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Phoenix Children's
Phoenix, Arizona, 85016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why do some preterm babies need breathing machines longer?
- A safer scan for tiny lungs: ultrasound may spot newborn pneumonia without radiation
- A Baby's fidgets may reveal brain health: study tests early warning signs
- Could a lung ultrasound spot preemie lung disease before it starts?
- Can gentle oscillations help premature babies breathe better?
- Could a Mother's Omega-3 supplement shield preterm Babies' lungs?